Cargando…
Angiotensin II infusion in COVID‐19: An international, multicenter, registry‐based study
To expand our understanding of the role of angiotensin II (ANGII) in coronavirus infectious disease 2019 (COVID‐19), we conducted an international, multicenter registry study to assess the use of ANGII in patients with COVID‐19 compared to patients not receiving ANGII. Critically ill adult patients...
Autores principales: | Serpa Neto, Ary, Landoni, Giovanni, Ostermann, Marlies, Lumlertgul, Nuttha, Forni, Lui, Alvarez‐Belon, Lucas, Trapani, Tony, Alliegro, Patricia V., Zacharowski, Kai, Wiedenbeck, Carolin, de Backer, Daniel, Bellomo, Rinaldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015246/ https://www.ncbi.nlm.nih.gov/pubmed/35029318 http://dx.doi.org/10.1002/jmv.27592 |
Ejemplares similares
-
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020) -
What every Intensivist should know about COVID-19 associated acute kidney injury
por: Ostermann, Marlies, et al.
Publicado: (2020) -
Acute kidney injury in ECMO patients
por: Ostermann, Marlies, et al.
Publicado: (2021) -
Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020) -
Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study)
por: Lumlertgul, Nuttha, et al.
Publicado: (2021)